1 |
CCN2
| [1] Hippo signaling pathway Hippo signaling pathway | D10969
D10969
|
Pamrevlumab
| [2] 85 85, 113 |
2 |
SMAD7
| [2] TGF-beta signaling pathway TGF-beta signaling pathway, Hippo signaling pathway | D10956
D10956
|
Mongersen
| [2] 96 96, 97 |
3 |
BMPR2
| [4] TGF-beta signaling pathway TGF-beta signaling pathway, Hippo signaling pathway, Signaling pathways regulating pluripotency of stem cells, MicroRNAs in cancer | D03779
D03779
|
Dibotermin alfa
| [1] 34 34 |
4 |
TGFB1
| [20] MAPK signaling pathway MAPK signaling pathway, TGF-beta signaling pathway, Osteoclast differentiation, Hippo signaling pathway, Th17 cell differentiation, Intestinal immune network for IgA production, Relaxin signaling pathway, Non-alcoholic fatty liver disease, Leishmaniasis, Malaria, Toxoplasmosis, Tuberculosis, Human T-cell leukemia virus 1 infection, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Pancreatic cancer, Inflammatory bowel disease, Rheumatoid arthritis, Hypertrophic cardiomyopathy | D09620
D09620
|
Fresolimumab
| [4] 51 51, 85, 222, 274 |
5 |
TGFB2
| [17] MAPK signaling pathway MAPK signaling pathway, TGF-beta signaling pathway, Osteoclast differentiation, Hippo signaling pathway, Leishmaniasis, Malaria, Toxoplasmosis, Tuberculosis, Human T-cell leukemia virus 1 infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Pancreatic cancer, Inflammatory bowel disease, Rheumatoid arthritis, Hypertrophic cardiomyopathy | D09620
D09620
|
Fresolimumab
| [4] 51 51, 85, 222, 274 |
6 |
TGFB3
| [14] MAPK signaling pathway MAPK signaling pathway, TGF-beta signaling pathway, Hippo signaling pathway, Leishmaniasis, Malaria, Toxoplasmosis, Tuberculosis, Human T-cell leukemia virus 1 infection, Pathways in cancer, Renal cell carcinoma, Pancreatic cancer, Inflammatory bowel disease, Rheumatoid arthritis, Hypertrophic cardiomyopathy | D09620
D09620
|
Fresolimumab
| [4] 51 51, 85, 222, 274 |